XBIOTECH INC. Shareholders' Equity
XBIOTECH INC. (XBIT) had Shareholders' Equity of $128.46 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $128.46M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $135.02M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $140.35M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $167.08M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $128.46M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $135.02M 10-Q · filed 2026-08-13 |
| 2025-12-31 | $140.35M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $167.08M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $173.06M 10-Q · filed 2026-08-13 |
| 2025-03-31 | $174.71M 10-Q · filed 2026-08-13 |
| 2024-12-31 | $182.27M 10-Q · filed 2026-08-13 |
| 2024-09-30 | $192.12M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $196.70M 10-Q · filed 2025-11-12 |
| 2024-03-31 | $209.28M 10-Q · filed 2025-08-13 |
| 2023-12-31 | $218.85M 10-K · filed 2026-03-13 |
| 2023-09-30 | $222.66M 10-Q · filed 2024-11-13 |
| 2023-06-30 | $229.06M 10-Q · filed 2024-11-13 |
| 2023-03-31 | $236.91M 10-Q · filed 2024-08-12 |
| 2022-12-31 | $240.40M 10-K · filed 2025-03-18 |
| 2022-09-30 | $244.81M 10-Q · filed 2023-11-09 |
| 2022-06-30 | $255.79M 10-Q · filed 2023-11-09 |
| 2022-03-31 | $265.56M 10-Q · filed 2023-08-11 |
| 2021-12-31 | $269.38M 10-K · filed 2024-03-15 |
| 2021-09-30 | $274.16M 10-Q · filed 2022-11-09 |
| 2021-06-30 | $348.56M 10-Q · filed 2022-11-09 |
| 2021-03-31 | $352.10M 10-Q · filed 2022-08-10 |
| 2020-12-31 | $348.64M 10-K · filed 2023-03-15 |
| 2020-09-30 | $346.14M 10-Q · filed 2021-11-09 |
| 2020-06-30 | $343.57M 10-Q · filed 2021-11-09 |
| 2020-03-31 | $347.08M 10-Q · filed 2021-08-09 |
| 2019-12-31 | $755.63M 10-K · filed 2022-03-15 |
| 2019-09-30 | $64.62M 10-Q · filed 2020-11-09 |
| 2019-06-30 | $69.41M 10-Q · filed 2020-11-09 |
| 2019-03-31 | $36.98M 10-Q · filed 2020-08-10 |
| 2018-12-31 | $41.40M 10-K · filed 2022-03-15 |
| 2018-09-30 | $46.94M 10-Q · filed 2019-11-12 |
| 2018-06-30 | $51.52M 10-Q · filed 2019-11-12 |
| 2018-03-31 | $56.41M 10-Q · filed 2019-08-09 |
| 2017-12-31 | $60.16M 10-K · filed 2021-03-16 |
| 2017-09-30 | $67.15M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $73.16M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $82.27M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $59.06M 10-K · filed 2020-03-16 |
| 2016-09-30 | $71.63M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $82.80M 10-Q · filed 2016-08-12 |
| 2016-03-31 | $94.68M 10-Q · filed 2016-05-13 |
| 2015-12-31 | $103.05M 10-K/A · filed 2019-03-15 |
| 2015-09-30 | $114.08M 10-Q · filed 2015-11-13 |
| 2015-06-30 | $123.97M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $54.86M 10-Q · filed 2015-06-18 |
| 2014-12-31 | $59.03M 10-K · filed 2018-03-16 |
| 2013-12-31 | $10.23M 10-K · filed 2017-03-16 |
| 2012-12-31 | $7.37M 10-K · filed 2016-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |